Ribavirin--current status of a broad spectrum antiviral agent
about
Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley FeverExtinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesisInsights into arbovirus evolution and adaptation from experimental studiesLassa fever in post-conflict sierra leoneT-705 (favipiravir) inhibition of arenavirus replication in cell cultureRespiratory viruses other than influenza virus: impact and therapeutic advancesMultiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreakReporter-Expressing, Replicating-Competent Recombinant ArenavirusesRibavirin: Past, present and futureReplication and Inhibitors of Enteroviruses and ParechovirusesNative functionality and therapeutic targeting of arenaviral glycoproteinsIn Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus InfectionsCounteracting Quasispecies Adaptability: Extinction of a Ribavirin-Resistant Virus Mutant by an Alternative Mutagenic TreatmentA Multi-Step Process of Viral Adaptation to a Mutagenic Nucleoside Analogue by Modulation of Transition Types Leads to Extinction-EscapeMutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing MutationsPotential benefits of sequential inhibitor-mutagen treatments of RNA virus infectionsA review of treatment modalities for Middle East Respiratory Syndrome.Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome.Development of a new tacaribe arenavirus infection model and its use to explore antiviral activity of a novel aristeromycin analog.Comparison of the chronic effects of ribavirin and caffeic acid phenethyl ester (CAPE) on pancreatic damage and hepatotoxicity.In vitro and in vivo activity of ribavirin against Andes virus infectionDrug discovery technologies and strategies for Machupo virus and other New World arenaviruses.Discovery of immunopotentiatory drugs: current and future strategies.Clinical aspects of Marburg hemorrhagic feverEffects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus.A treatment for and vaccine against the deadly Hendra and Nipah virusesHendra and nipah infection: pathology, models and potential therapies.Emerging paramyxoviruses: molecular mechanisms and antiviral strategiesHigh-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection.Novel and re-emerging respiratory infections.A cell-based high-throughput approach to identify inhibitors of influenza A virus.Thyroid dysfunction in chinese patients with chronic hepatitis C treated with interferon alpha: incidence, long-term outcome and predictive factors.Developments towards effective treatments for Nipah and Hendra virus infection.Development of novel entry inhibitors targeting emerging viruses.Nipah virus: vaccination and passive protection studies in a hamster model.Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.Targeted strategies for henipavirus therapeuticsRibavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome--after intranasal exposure to Andes virusShort Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells.Reverse Genetics Approaches to Control Arenavirus.
P2860
Q21092271-A2453DEB-68D6-4B67-B36B-B48DB28DEBC2Q21132564-883306A2-EC58-4050-B98B-F03615369582Q24273306-5133D135-03A2-4E96-B1FA-F105D630892AQ24290732-3884D895-44A5-4688-AD8C-8C07BF580A53Q24633241-6239F123-8FB0-4C4E-A7C9-821BCF2FEDE1Q24655957-21957427-6E10-4367-B1EB-65BCEEACD903Q24701722-FB37E317-8049-46E5-8196-91FAFC460439Q26742028-FA59F916-5BFA-4A79-A0DA-19A32CE3BAFCQ26775002-CB076E7B-3254-47EC-9F7D-9F02EABE5094Q26798463-45372151-3D4C-4098-9338-DFEF0FD369D7Q26827679-6567B844-002C-4AC4-B081-D8EE88205AF6Q27481401-AD1F7904-A67D-4F2C-8759-F6ED94F3FE6AQ27488361-A530B49C-8CC8-4779-A5A5-28DA543F7BE0Q27664656-51565B14-60B4-42B2-B112-5E2BBA41678AQ28072953-D68F759B-B164-49D0-B540-5230CBC0100EQ28471847-9AF617E2-69EE-43EE-91A2-7E960AF2210EQ30248209-66205BE2-C50D-4087-ACED-FE11277EA950Q33409920-1DE6A4AA-A11B-47EC-924A-FDBA42AAE578Q33700461-9AD619DA-5639-49FA-8821-6BC7098B00C2Q33756297-119415BD-1FEC-44B7-83E1-F8C196DFDED3Q33997268-FF375B92-E492-430B-8F5A-535AF98AD305Q34274569-2B5564A6-3A00-462A-94E4-63C9C6D93E25Q35009482-8A2CEA4D-E255-4743-8254-8D580BB4EDF1Q35446144-21FB1909-6CB2-42E6-8025-0B67D44E0C0CQ35548601-88E8B8B2-6DEB-44D9-ACEC-6806909940B7Q35565878-05FF2418-6E36-4498-90D1-F3C3CA728E2AQ35658146-7B4ABD0D-2CBB-4032-9770-AAD13799078FQ35658152-00BDD49D-C7C7-496C-A3DD-3A2A749DD4AEQ35893112-D41EBA1F-D7DD-41D6-B052-2C9DF5BCCE84Q35917425-48A2CF9B-893F-4A52-98D1-70BA87710190Q36237545-4141E4E9-F9FB-48F8-B68D-74F512F62EE1Q36329350-530794D5-F28B-456A-86CE-9C0A8CD287A8Q36379335-012A8CE5-1D03-4C09-9A9E-5EB943A31801Q36655280-017038F9-E217-4399-AAE8-4DAE5C716445Q36944615-3422E18B-7E81-4264-96B5-503463D4C9FEQ37018993-82538A03-DE58-4A34-A402-0D62BD681731Q37175177-98526A28-E875-4BA3-BF80-DC1772B74D32Q37376384-11528BEA-F1F7-4A21-807D-0588919AADEAQ37433779-C7634784-A667-47D1-B1AF-C29BF88A661BQ37543755-07F1B96E-63C7-41AC-B638-481825BF7C89
P2860
Ribavirin--current status of a broad spectrum antiviral agent
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Ribavirin--current status of a broad spectrum antiviral agent
@ast
Ribavirin--current status of a broad spectrum antiviral agent
@en
Ribavirin--current status of a broad spectrum antiviral agent
@nl
type
label
Ribavirin--current status of a broad spectrum antiviral agent
@ast
Ribavirin--current status of a broad spectrum antiviral agent
@en
Ribavirin--current status of a broad spectrum antiviral agent
@nl
prefLabel
Ribavirin--current status of a broad spectrum antiviral agent
@ast
Ribavirin--current status of a broad spectrum antiviral agent
@en
Ribavirin--current status of a broad spectrum antiviral agent
@nl
P2860
P3181
P1476
Ribavirin--current status of a broad spectrum antiviral agent
@en
P2093
P2860
P304
P3181
P356
10.1517/14656566.2.8.1317
P407
P577
2001-08-01T00:00:00Z